Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

TherapeuticsMD Q1 EPS $(0.06) Up From $(0.07) YoY, Sales $393.00K Up From $313.00K YoY

Author: Benzinga Newsdesk | May 13, 2025 06:31pm
TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.06) per share. This is a 14.29 percent increase over losses of $(0.07) per share from the same period last year. The company reported $393.00 thousand in sales this quarter. This is a 25.56 percent increase over sales of $313.00 thousand the same period last year.

Posted In: TXMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist